Artrya Limited (ASX:AYA)
Australia · Delayed Price · Currency is AUD 3.340
-0.400 (-10.70%)
Nov 14, 2025, 10:09 AM AEST
Artrya Market Cap
Artrya has a market cap or net worth of 590.86 million as of November 13, 2025. Its market cap has increased by 1,567.25% in one year.
Market Cap
590.86M
Enterprise Value
580.15M
Revenue
28.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
3.34
Market Cap Chart
Since November 26, 2021, Artrya's market cap has increased from 119.12M to 590.86M, an increase of 396.01%. That is a compound annual growth rate of 49.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2025 | 568.74M | 1,073.05% |
| Dec 31, 2024 | 48.48M | 156.86% |
| Dec 29, 2023 | 18.88M | -39.81% |
| Dec 30, 2022 | 31.36M | -69.23% |
| Dec 31, 2021 | 101.94M | -14.43% |
| Nov 26, 2021 | 119.12M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 86.09B |
| Pro Medicus | 26.64B |
| Cochlear | 18.86B |
| Sonic Healthcare | 10.41B |
| Ramsay Health Care | 7.04B |
| Telix Pharmaceuticals | 5.29B |
| Ansell | 5.22B |
| Mesoblast | 2.96B |